Skip to main content

What the FDA labels say about taking them together

Corticotropin and mitotane

Mitotane's FDA label of March 3, 2026 names corticotropin in its warnings and precautions section; the corticotropin labels PlainMeds reads (2) do not name mitotane. The mitotane label: “Due to increased steroid clearance and increase of steroid-binding protein, high-dose replacement therapy may be required and free cortisol and corticotropin (ACTH) should be monitored to adapt the systemic …”

Check it at the source: the corticotropin FDA label on DailyMed (effective July 15, 2026, Mallinckrodt ARD LLC); the mitotane FDA label on DailyMed (effective March 3, 2026, ESTEVE PHARMACEUTICALS, S.A.).

What does the corticotropin label say about mitotane?

Corticotropin's label (effective July 15, 2026) and its 1 other brand-application label do not name mitotane in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Acthar), Mallinckrodt ARD LLC, effective July 15, 2026 (SPL set 7b48ddec-e815-45f4-9ca0-5c0daaf56f30), via openFDA; the full label on DailyMed

What does the mitotane label say about corticotropin?

Mitotane label, warnings and precautions

Due to increased steroid clearance and increase of steroid-binding protein, high-dose replacement therapy may be required and free cortisol and corticotropin (ACTH) should be monitored to adapt the systemic corticosteroids.

Source: FDA drug label (Lysodren), ESTEVE PHARMACEUTICALS, S.A., effective March 3, 2026 (SPL set 4046a224-8832-daa2-e063-6294a90a11d7), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Corticotropin generic labelers
0Mitotane generic labelers
CorticotropinMitotane
Labeled forMultiple sclerosis, Psoriasis, Eczema (atopic dermatitis)n/a
Boxed warningNoYes
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?